🔗 Share this article

Treasury head Reeves has revealed she is preparing "targeted steps to deal with cost of living issues" in the upcoming financial statement.

Speaking to the BBC, she noted that lowering price rises is a shared duty of both the administration and the central bank.

The UK's price growth is projected to be the highest among the G7 industrialized countries this year and the following year.

Possible Utility Bill Measures

Reports indicate the government could take action to lower energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy supplies.

Another option is to reduce some of the regulatory levies presently included in bills.

Fiscal Limitations and Expert Expectations

The administration will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such actions.

The expectation from most analysts is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her self-imposed debt limits.

Previously on Thursday, calculations showed there was a £22 billion deficit for the Treasury chief to resolve, which is at the more modest range of projections.

"There's a shared job between the Bank of England and the administration to continue tackling some of the causes of inflation," Reeves stated to the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Issues

While a great deal of the focus has been on probable tax rises, the chancellor said the latest figures from the fiscal watchdog had not changed her pledge to election pledges not to increase rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with growing geopolitical and commercial issues for the fiscal revenue measures, probably to be targeted on those "most able to pay."

Global Economic Disputes

Addressing apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests invariably come first."

Last week's statement by Chinese authorities to tighten trade restrictions on rare earths and other materials that are crucial for advanced tech manufacturing led American leader Donald Trump to suggest an extra 100% import tax on imports from the Asian country, increasing the risk of an all-out trade war between the two economic giants.

The American finance chief called China's move "commercial pressure" and "a international production control attempt."

Questioned on accepting the US offer to participate in its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "bad for the world economy and generates additional headwinds."

"In my view there are sectors where we need to confront China, but there are also valuable opportunities to export to Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance correct."

The chancellor also stated she was collaborating with other major economies "on our own critical minerals approach, so that we are more independent."

Health Service Drug Pricing and Investment

Reeves also recognized that the price the NHS pays for drugs could rise as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global drug companies have said lately that they are either delaying or scrapping operations in the United Kingdom, with some attributing the modest returns they are getting.

Last month, the Science Minister said the cost the health service spends on medicines would must rise to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "We have seen as a result of the payment system, that drug testing, new drugs have not been offered in the United Kingdom in the manner that they are in other European countries."

"The objective is to ensure that patients receiving care from the NHS are can access the finest life-saving drugs in the globe. And so we are reviewing this situation, and... seeking to obtain more capital into the UK."